重症肌无力中的免疫复合物
Immune complexes in myasthenia gravis.
作者信息
Behan W M, Behan P O
出版信息
J Neurol Neurosurg Psychiatry. 1979 Jul;42(7):595-9. doi: 10.1136/jnnp.42.7.595.
Abstract
Complement components were measured and immune complexes were sought in 75 patients with myasthenia gravis. Thirty-four per cent had decreased concentrations of complement component C4, and 29% had circulating immune complexes. The greatest immunological abnormalities were found in patients with mild disease which supports recent immunoelectronmicroscopic findings.
摘要
对75例重症肌无力患者检测了补体成分并查找免疫复合物。34%的患者补体成分C4浓度降低，29%的患者有循环免疫复合物。在轻症患者中发现了最严重的免疫学异常，这与最近的免疫电子显微镜检查结果相符。
相似文献
1
Immune complexes in myasthenia gravis.重症肌无力中的免疫复合物
J Neurol Neurosurg Psychiatry. 1979 Jul;42(7):595-9. doi: 10.1136/jnnp.42.7.595.
2
Letter: Immune complexes in myasthenia gravis.信件：重症肌无力中的免疫复合物
Lancet. 1976 Aug 14;2(7981):378. doi: 10.1016/s0140-6736(76)92644-1.
3
Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis.IgG、C3和C9在轻度重症肌无力肢体肌肉运动终板处的诊断意义
Neurology. 1989 Oct;39(10):1359-63. doi: 10.1212/wnl.39.10.1359.
4
High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis.高白细胞介素-10产生与青少年重症肌无力患者抗乙酰胆碱受体抗体产生及治疗反应相关。
Int J Neurosci. 2007 Nov;117(11):1505-12. doi: 10.1080/00207450601125840.
5
Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.实验性自身免疫性重症肌无力中血清抗C1q抗体水平的预测价值
Neuromuscul Disord. 2006 Feb;16(2):137-43. doi: 10.1016/j.nmd.2005.11.005. Epub 2006 Jan 19.
6
Circulating immune complexes in myasthenia gravis.重症肌无力中的循环免疫复合物
Rev Hosp Clin Fac Med Sao Paulo. 1985 Jan-Feb;40(1):13-4.
7
Immune complexes in myasthenia gravis.重症肌无力中的免疫复合物
J Clin Lab Immunol. 1981 Jan;5(1):27-30.
8
[Circulating immune complexes and myasthenia gravis (analysis of 78 cases)].[循环免疫复合物与重症肌无力（78例分析）]
Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1990 Jun;23(3):130-2, 188.
9
[Detection of erythrocyte immune function and circulatory immune complex in myasthenia gravis].
Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1990 Jun;23(3):133-5, 188.
10
Significance of circulating immune complexes in myasthenia gravis.循环免疫复合物在重症肌无力中的意义。
Indian J Med Res. 2000 May;111:180-3.
引用本文的文献
1
The role of complement in the immunopathogenesis of acetylcholine receptor antibody-positive generalized myasthenia gravis: bystander or key player?补体在乙酰胆碱受体抗体阳性全身型重症肌无力免疫发病机制中的作用：旁观者还是关键参与者？
Front Immunol. 2025 Apr 15;16:1526317. doi: 10.3389/fimmu.2025.1526317. eCollection 2025.
2
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.重症肌无力补体活性与自身抗体滴度和疾病严重程度无关。
PLoS One. 2022 Mar 15;17(3):e0264489. doi: 10.1371/journal.pone.0264489. eCollection 2022.
3
Controversies about the treatment of myasthenia gravis.重症肌无力治疗方面的争议。
J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):644-59. doi: 10.1136/jnnp.43.7.644.
4
Circulating immune complexes in myasthenia gravis: a study in relation to thymectomy, clinical severity and thymus histology.重症肌无力患者循环免疫复合物：一项关于胸腺切除术、临床严重程度及胸腺组织学的研究
J Neurol Neurosurg Psychiatry. 1981 Oct;44(10):901-5. doi: 10.1136/jnnp.44.10.901.
5
Immune disease and HLA associations with myasthenia gravis.免疫性疾病及HLA与重症肌无力的关联
J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):611-21. doi: 10.1136/jnnp.43.7.611.
本文引用的文献
1
ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.抗原-抗体交叉电泳
Anal Biochem. 1965 Feb;10:358-61. doi: 10.1016/0003-2697(65)90278-2.
2
Changes in serum complement activity in patients with myasthenia gravis.重症肌无力患者血清补体活性的变化
Proc Soc Exp Biol Med. 1960 Oct;105:177-84. doi: 10.3181/00379727-105-26050.
3
Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis.在重症肌无力患者的血液中寻找神经肌肉阻滞剂。
Am J Med. 1959 Mar;26(3):394-409. doi: 10.1016/0002-9343(59)90248-7.
4
Autoimmune response to acetylcholine receptor.对乙酰胆碱受体的自身免疫反应。
Science. 1973 May 25;180(4088):871-2. doi: 10.1126/science.180.4088.871.
5
Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.重症肌无力中的血清球蛋白：对α-银环蛇毒素与乙酰胆碱受体结合的抑制作用
Science. 1974 Oct 4;186(4158):55-7. doi: 10.1126/science.186.4158.55.
6
Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.反应性溶解：补体介导的未致敏细胞溶解。I. 指示因子的特性及其鉴定为C7。
J Exp Med. 1970 Apr 1;131(4):629-41. doi: 10.1084/jem.131.4.629.
7
Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis.重症肌无力患者对富含乙酰胆碱受体组分的细胞免疫反应。
Clin Exp Immunol. 1975 Jan;19(1):11-6.
8
Myasthenia gravis: passive transfer from man to mouse.重症肌无力：从人到小鼠的被动转移
Science. 1975 Oct 24;190(4212):397-9. doi: 10.1126/science.1179220.
9
Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.重症肌无力中乙酰胆碱受体抗体。患病率、临床相关性及诊断价值。
Neurology. 1976 Nov;26(11):1054-9. doi: 10.1212/wnl.26.11.1054.
Zotero 插件